forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide vs. Semaglutide: What You Should Know GLP-1s in 2025: Who's Using

The needle dulls slightly with each puncture, the inside is no longer sterile after first use, and the risk of contaminating the vial rises every time

The landmark SELECT trial demonstrated that weekly semaglutide 2.4 mg reduces major cardiovascular events by 20% in people with obesity or overweight and established heart diseaseeven in those without diabetes.[1] This finding represents a paradigm shift in cardiovascular prevention, as it's the first time a weight-loss medication has been proven to directly reduce heart attacks, strokes, and cardiovascular deaths

Here are some ways you can address this issue: Supplements: If you have a mild to moderate deficiency, take vitamin B12 supplements to maintain adequate levels

Improved adherence: For those who struggle with remembering weekly doses, twice-weekly administration might be easier to incorporate into their routine

What is GHK-CU used for in research

Diabetes Res Clin Pract 2024